CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors

Background While cancer vaccines have demonstrated promising clinical potential, their therapeutic efficacy against advanced tumors remains suboptimal, highlighting the critical need to elucidate resistance mechanisms and develop targeted solutions. We previously developed a stimulator of interferon...

Full description

Bibliographic Details

Main Authors:	Miaomiao Yang, Min Luo, Mengyan Wang, Yuwei Li, Zhigang Lu, Xianglei Wang, Shiyao Xue, Haotian Yu, Suxin Li
Format:	Artigo
Language:	Inglês
Published:	BMJ Publishing Group 2026-01-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/14/1/e013336.full
Tags:	Add Tag No Tags, Be the first to tag this record!